Header Logo

Connection

FERDINANDOS SKOULIDIS to Pyrimidines

Back to Details
This is a "connection" page, showing publications FERDINANDOS SKOULIDIS has written about Pyrimidines.
FERDINANDOS SKOULIDIS
Connection Strength
0.565
Pyrimidines
  1. Sotorasib for Lung Cancers with KRAS p.G12C Mutation. N Engl J Med. 2021 06 24; 384(25):2371-2381.
    View in: PubMed
    Score: 0.312
  2. Real-World Efficacy and Safety of Amivantamab for EGFR-Mutant NSCLC. J Thorac Oncol. 2024 03; 19(3):500-506.
    View in: PubMed
    Score: 0.092
  3. Clinical validation of Guardant360 CDx as a blood-based companion diagnostic for sotorasib. Lung Cancer. 2022 04; 166:270-278.
    View in: PubMed
    Score: 0.080
  4. Targeting the Gatekeeper: Osimertinib in EGFR T790M Mutation-Positive Non-Small Cell Lung Cancer. Clin Cancer Res. 2017 Feb 01; 23(3):618-622.
    View in: PubMed
    Score: 0.057
  5. Mutational Characteristics and Clinical Outcomes for Lung Adenocarcinoma With EGFR Germline Mutations. J Thorac Oncol. 2024 Oct; 19(10):1438-1448.
    View in: PubMed
    Score: 0.024
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.